Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinflunine plus Gemcitabine in Advanced TCC
NCT00389155Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jan 2007
- Primary completion
- Jan 2008
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of vinflunine in transitional cell carcinoma (TCC), sponsored by Bristol Myers Squibb. Started Jan 2007; status: completed.
02
Drugs
vinflunine
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on NCT00389155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00389155.